ARCHIVES

FDA Approves Abraxane And Alimta for NSCLC

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Comprehensive Centers Should Emphasize New Treatment, Group Says

July 27, 1979

In Brief: Bernard Fisher Professorship Endowed By ICI Pharma; Brady Wins RSNA Medal

January 5, 1990

Lame Duck NCI Director: Cancer Centers Should Run Cancer Clinical Trials System

June 25, 2010

Computer-Aided Detection Approved For Mammograms.

December 14, 2001

Shingleton Nominated To President’s Panel

June 10, 1977

Bush Signs Bill To Increase Blood Cancer Research.

May 17, 2002